EGFR and central nervous system cancer: Our genomic microarray data and validation results, showing higher EGFR mRNA as well as MAP2K mRNA levels in G2 glioma grade compared to G3 and G4 grade, provide new information regarding the genetic status of low-grade glioma in adults.